Turkmenistan vs Uganda: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Turkmenistan
0.3%
in 2024
Uganda
0.3%
in 2024
Turkmenistan rank
85th
Uganda rank
85th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Turkmenistan
- Uganda
How they compare
Turkmenistan currently reports 0.3% against 0.3% in Uganda, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2015 it was Uganda ahead.
Turkmenistan ranks 85th and Uganda ranks 85th of 246 countries.
Across the 2 decades both report, Turkmenistan averaged higher in 1 and Uganda in 1.
Head to head by decade
| Decade | Turkmenistan | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.4% | 0.0% | Turkmenistan |
| 2020s | 0.3% | 0.4% | 0.1% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Turkmenistan or Uganda?
- Turkmenistan, at 0.3% against 0.3% in Uganda as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Turkmenistan and Uganda?
- 0.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Turkmenistan and Uganda?
- 10 years are reported by both, from 2015 to 2024.
- How do Turkmenistan and Uganda rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Turkmenistan ranks 85th and Uganda ranks 85th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.